For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...

The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Second, there is a greater chance of drug interactions. Azole antifungals (e.g., fluconazole, itraconazole and voriconazole) alter metabolism of cyclophosphamide, a cytotoxic agent, through ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Opelconazole is a potent novel investigational azole therapy specifically designed for inhaled ... of adding to the toxicities and drug-drug interactions seen with systemic antifungal therapies.

Azole Therapy: A class of antifungal medications used to treat fungal infections, including those caused by invasive fungi. This Nature Research Intelligence Topic summary is one of 30,000 created ...

Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 ...

the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive fungal infections. “We are pleased to advance our potent, second SCYNEXIS ( NASDAQ ...

Perform susceptibility testing as an adjunctive to treatment for patients with disease and long-term azole treatment and/or recurrent cultivation of an Aspergillus spp. Perform susceptibility ...